View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.
Authors: Phillips PPJ; UCSF Center for Tuberculosis and.; Department of Medicine, University of California, San Francisco, San Francisco, California., Peloquin CA; College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, Florida., Sterling TR; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Kaur P; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts., Diacon AH; TASK, Cape Town, South Africa., Gotuzzo E; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru., Benator D; Infectious Diseases Section, Washington DC Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia., Warren RM; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Science, SAMRC Centre for Tuberculosis, Stellenbosch University, Cape Town, South Africa., Sikes D; Laboratory Branch, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia., Lecca L; Socios En Salud Sucursal Perú, Lima, Peru., Gandhi NR; Departments of Epidemiology, Global Health, and Medicine and Emory/Georgia Tuberculosis Research Advancement Center, Emory University, Atlanta, Georgia., Streicher EM; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Science, SAMRC Centre for Tuberculosis, Stellenbosch University, Cape Town, South Africa., Dianis N; Westat, Bethesda, Maryland., Eisenach K; TB or NOT TB Consulting, LLC, Little Rock, Arkansas., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts; and., Horsburgh CR Jr; Departments of Epidemiology, Biostatistics, Global Health, and Medicine, Boston University Schools of Public Health and Medicine, Boston, Massachusetts.
Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2025 Jul; Vol. 211 (7), pp. 1277-1287.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Thoracic Society Country of Publication: England NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40080768
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Phillips+PPJ%22">Phillips PPJ</searchLink>; UCSF Center for Tuberculosis and.; Department of Medicine, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Peloquin+CA%22">Peloquin CA</searchLink>; College of Pharmacy and Emerging Pathogens Institute, University of Florida, Gainesville, Florida.<br /><searchLink fieldCode="AU" term="%22Sterling+TR%22">Sterling TR</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Kaur+P%22">Kaur P</searchLink>; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Diacon+AH%22">Diacon AH</searchLink>; TASK, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Gotuzzo+E%22">Gotuzzo E</searchLink>; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.<br /><searchLink fieldCode="AU" term="%22Benator+D%22">Benator D</searchLink>; Infectious Diseases Section, Washington DC Veterans Affairs Medical Center, George Washington University, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Warren+RM%22">Warren RM</searchLink>; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Science, SAMRC Centre for Tuberculosis, Stellenbosch University, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Sikes+D%22">Sikes D</searchLink>; Laboratory Branch, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Lecca+L%22">Lecca L</searchLink>; Socios En Salud Sucursal Perú, Lima, Peru.<br /><searchLink fieldCode="AU" term="%22Gandhi+NR%22">Gandhi NR</searchLink>; Departments of Epidemiology, Global Health, and Medicine and Emory/Georgia Tuberculosis Research Advancement Center, Emory University, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Streicher+EM%22">Streicher EM</searchLink>; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Science, SAMRC Centre for Tuberculosis, Stellenbosch University, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Dianis+N%22">Dianis N</searchLink>; Westat, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Eisenach+K%22">Eisenach K</searchLink>; TB or NOT TB Consulting, LLC, Little Rock, Arkansas.<br /><searchLink fieldCode="AU" term="%22Mitnick+CD%22">Mitnick CD</searchLink>; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts; and.<br /><searchLink fieldCode="AU" term="%22Horsburgh+CR+Jr%22">Horsburgh CR Jr</searchLink>; Departments of Epidemiology, Biostatistics, Global Health, and Medicine, Boston University Schools of Public Health and Medicine, Boston, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229421642%22">American journal of respiratory and critical care medicine</searchLink> [Am J Respir Crit Care Med] 2025 Jul; Vol. 211 (7), pp. 1277-1287.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Thoracic+Society%22">American Thoracic Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9421642 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-4970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221073449X%22">1073449X </searchLink><i>NLM ISO Abbreviation: </i>Am J Respir Crit Care Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40080768
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1164/rccm.202407-1354OC
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1277
    Titles:
      – TitleFull: Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Phillips PPJ
      – PersonEntity:
          Name:
            NameFull: Peloquin CA
      – PersonEntity:
          Name:
            NameFull: Sterling TR
      – PersonEntity:
          Name:
            NameFull: Kaur P
      – PersonEntity:
          Name:
            NameFull: Diacon AH
      – PersonEntity:
          Name:
            NameFull: Gotuzzo E
      – PersonEntity:
          Name:
            NameFull: Benator D
      – PersonEntity:
          Name:
            NameFull: Warren RM
      – PersonEntity:
          Name:
            NameFull: Sikes D
      – PersonEntity:
          Name:
            NameFull: Lecca L
      – PersonEntity:
          Name:
            NameFull: Gandhi NR
      – PersonEntity:
          Name:
            NameFull: Streicher EM
      – PersonEntity:
          Name:
            NameFull: Dianis N
      – PersonEntity:
          Name:
            NameFull: Eisenach K
      – PersonEntity:
          Name:
            NameFull: Mitnick CD
      – PersonEntity:
          Name:
            NameFull: Horsburgh CR Jr
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1535-4970
          Numbering:
            – Type: volume
              Value: 211
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: American journal of respiratory and critical care medicine
              Type: main
ResultId 1